BofA Finance LLC files pricing supplement for yield notes
BofA Finance LLC announces $500,000 in contingent income buffered issuer callable yield notes linked to major indices, enhancing its offerings in national commercial banking.
Generate Biomedicines Director Sells Over 11,000 Shares
Frances Arnold, Director of Generate Biomedicines, sells 11,409 shares in a recent SEC filing, impacting perceptions in the pharmaceutical industry.
Bayview MSR Opportunity Domestic 3, L.P. amends offering details
Bayview MSR Opportunity Domestic 3, L.P. has amended its offering, revealing over $3.4 billion raised as it continues its fundraising strategy.
EQT to Acquire Range Resources in $13 Billion Merger Deal
EQT Corporation announces a $13 billion acquisition of Range Resources, creating the largest natural gas producer in the U.S. and enhancing operational efficiencies.
Barclays Bank announces $50,000 Autocallable Notes offering
Barclays Bank PLC files for $50,000 in Autocallable Leveraged Barrier Notes, enhancing its financial offerings in the competitive commercial banking sector.
Barclays Bank announces Autocallable Buffered Notes offering
Barclays Bank PLC files for Autocallable Buffered Notes linked to the US Tech Accelerator Index, diversifying its offerings in the commercial banking sector.
JPMorgan Chase Financial Co. unveils new structured notes
JPMorgan Chase Financial Co. LLC announces a new structured investment product worth $420,000, fully guaranteed by JPMorgan Chase & Co.
Ellen M. Lord to Sell 4,341 Shares of AAR Corp Stock
Ellen M. Lord, director at AAR Corp, files to sell 4,341 shares of stock, reflecting ongoing changes in executive holdings in the Aircraft & Parts industry.
BofA Finance LLC files pricing supplement for new notes
BofA Finance LLC has filed a pricing supplement for Buffered Digital Return Notes linked to the Invesco Nasdaq 100 ETF, totaling $481,000.
Coller Secondaries Fund Reports Financial Results for Q3 2026
Coller Secondaries Private Equity Opportunities Fund releases its Q3 2026 financial results, highlighting significant asset management strategies.
Coller Private Credit Secondaries Reports Financial Update
Coller Private Credit Secondaries shares its latest financials, revealing asset and liability figures that reflect its position in the investment management industry.
HSBC USA Inc. Launches New Buffered Securities Offering
HSBC USA Inc. introduces Buffered Accelerated Market Participation Securities linked to the Nasdaq-100 Index, enhancing its investment product lineup.
BFC Planning, Inc. Reports $2.46 Billion in Holdings
BFC Planning, Inc. reveals $2.46 billion in holdings in its latest 13F-HR filing, showcasing its investment strategy and market positions.
Royal Bank of Canada launches Buffered PLUS securities
Royal Bank of Canada introduces Buffered PLUS securities linked to the EURO STOXX 50 Index, expanding its investment offerings.
Morgan Stanley Finance LLC Files New Pricing Supplement
Morgan Stanley Finance LLC files a new pricing supplement for structured investments, reflecting strategic moves in the competitive securities industry.
Capital Management Corp reports $667.5 million in holdings
Capital Management Corp's recent SEC filing reveals $667.5 million in holdings, showcasing its investment strategies and key positions in major companies.
X Hypershell LP Files New Offering Under Rule 506(b)
X Hypershell LP has filed a new offering under Rule 506(b), focusing on venture capital investments in a competitive market.
Greenbird Intelligence Fund files new private equity offering
Greenbird Intelligence Fund, LLC, Series ZC - Anduril has filed a new offering, raising over $800,000 in private equity under Rule 506(b).
Bank of Montreal announces new market-linked notes offering
Bank of Montreal files for new market-linked notes, emphasizing innovation in financial products within the commercial banking sector.
Decheng Capital Reports 4.9% Stake in Upstream Bio, Inc.
Decheng Capital Global Life Sciences Fund IV, L.P. discloses a 4.9% stake in Upstream Bio, Inc., indicating ongoing investor interest in the pharmaceutical sector.